MyoKardia Inc (MYOK)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

1000 SIERRA POINT PARKWAY BRISBANE, CA 94005

MyoKardia, Inc. operates as a precision cardiovascular medicine company. The Company develops and commercializes targeted therapies for the treatment of serious and neglected rare cardiovascular diseases. MyoKardia conducts its business in the United States.

Data as of 2020-05-24
Market Cap5.018 Billion Shares Outstanding46.681 Million Avg 30-day Volume1.014 Million
P/E Ratio Dividend Yield EPS-6.66
Price/Sales Price cash flow ratio179.1 Price free cash flow ratio-18.0
Book Value7.48 Price to Tangible Book14.37 Alpha
Short Interest Ratio % Short Interest to Float R-squared
BETA 52-week High/Low126.301 / 42.65 Stddev
View SEC Filings from MYOK instead.

View recent insider trading info

Funds Holding MYOK (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding MYOK BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

46.3 Thousand total shares from 17 transactions

Exercise Derivative Conversion (M)

15.3 Thousand total shares from 2 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

TOPOL ERIC

  • Director
91,847 2020-05-22 0

GIANAKAKOS ANASTASIOS PRESIDENT AND CEO

  • Officer
  • Director
634,790 2020-05-18 22

YARNO WENDY L

  • Director
0 2020-05-14 1

PERRY MARK L

  • Director
26,428 2020-05-12 1

CRANSTON MARY B

  • Director
50,740 2020-04-28 1

FOX JONATHAN C SEE REMARKS

  • Officer
406,475 2020-04-23 0

HARRIS TAYLOR C. CHIEF FINANCIAL OFFICER

  • Officer
7,438 2020-04-04 4

HOMCY CHARLES J CHAIRMAN OF PHARMACEUTICALS

  • Officer
  • Director
1,302,291 2020-04-03 0

POPOVITS KIMBERLY J

  • Director
0 2020-03-26 1

SANOFI

23,221,451 2020-03-09 0

BAUER JAKE CHIEF BUSINESS OFFICER

  • Officer
0 2020-02-14 7

MCDOWELL ROBERT SCOTT CHIEF SCIENTIFIC OFFICER

  • Officer
0 2020-02-14 3

LADD CYNTHIA J GENERAL COUNSEL

  • Officer
0 2020-02-14 3

FAIREY WILLIAM SEE REMARKS

  • Officer
0 2020-02-14 2

LEE JUNE EVP, CHIEF DEVELOPMENT OFFICER

  • Officer
4,153 2019-09-23 3

LEVIN MARK J

  • Director
  • 10% Owner
5,962,202 2019-07-22 0

MEEKER DAVID P

  • Director
0 2019-06-19 1

AGARWAL SUNIL

  • Director
0 2019-06-13 1

STARR KEVIN P

0 2019-06-05 0

LAMBING JOSEPH SEE REMARKS

  • Officer
0 2019-02-08 0

SEMIGRAN MARC CHIEF MEDICAL OFFICER

  • Officer
0 2019-02-08 0

CHAN STEVEN SEE REMARKS

  • Officer
0 2019-01-16 0

MCDOWELL ROBERT SCOTT CHIEF SCIENTIFIC OFFICER

MCDOWELL ROBERT SCOTT CHIEF SCIENTIFIC OFFICER

  • Officer
1,158 2019-01-07 3

THIRD ROCK VENTURES II, L.P.

THIRD ROCK VENTURES GP II, L.P.

TRV GP II, LLC

LEVIN MARK J

TEPPER ROBERT I

  • 10% Owner
No longer subject to file 2018-03-07 0

THIRD ROCK VENTURES III, L.P.

THIRD ROCK VENTURES GP III, L.P.

TRV GP III, LLC

LEVIN MARK J

TEPPER ROBERT I

  • 10% Owner
1,102,356 2018-01-03 0

THIRD ROCK VENTURES II, L.P.

THIRD ROCK VENTURES GP II, L.P.

TRV GP II, LLC

THIRD ROCK VENTURES III, L.P.

THIRD ROCK VENTURES GP III, L.P.

TRV GP III, LLC

LEVIN MARK J

TEPPER ROBERT I

  • 10% Owner
1,496,598 2015-11-03 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

GIANAKAKOS ANASTASIOS - Director - Officer PRESIDENT AND CEO

2020-05-18 S 10,000 $125.00 d 29,122 634,790.00 direct yes

GIANAKAKOS ANASTASIOS - Director - Officer PRESIDENT AND CEO

2020-05-11 S 600 $103.33 d 39,122 644,790.00 direct yes

GIANAKAKOS ANASTASIOS - Director - Officer PRESIDENT AND CEO

2020-05-11 S 1,700 $100.51 d 61,822 644,790.00 direct yes

GIANAKAKOS ANASTASIOS - Director - Officer PRESIDENT AND CEO

2020-05-11 S 3,519 $102.56 d 39,722 644,790.00 direct yes

GIANAKAKOS ANASTASIOS - Director - Officer PRESIDENT AND CEO

2020-05-11 S 600 $98.69 d 63,522 644,790.00 direct yes

GIANAKAKOS ANASTASIOS - Director - Officer PRESIDENT AND CEO

2020-05-11 S 18,581 $101.90 d 43,241 644,790.00 direct yes

GIANAKAKOS ANASTASIOS - Director - Officer PRESIDENT AND CEO

2020-05-04 S 2,909 $59.10 d 74,427 669,790.00 direct yes

GIANAKAKOS ANASTASIOS - Director - Officer PRESIDENT AND CEO

2020-05-04 S 400 $58.05 d 77,336 669,790.00 direct yes

GIANAKAKOS ANASTASIOS - Director - Officer PRESIDENT AND CEO

2020-05-04 S 305 $60.15 d 74,122 669,790.00 direct yes

GIANAKAKOS ANASTASIOS - Director - Officer PRESIDENT AND CEO

2020-05-04 S 1,386 $56.93 d 77,736 669,790.00 direct yes

GIANAKAKOS ANASTASIOS - Director - Officer PRESIDENT AND CEO

2020-04-30 M 11,500 d 121,626 674,790.00 direct

GIANAKAKOS ANASTASIOS - Director - Officer PRESIDENT AND CEO

2020-04-30 M 11,500 $1.51 a 289,582 674,790.00 direct

GIANAKAKOS ANASTASIOS - Director - Officer PRESIDENT AND CEO

2020-04-30 A 421 $50.41 a 278,082 674,790.00 direct

GIANAKAKOS ANASTASIOS - Director - Officer PRESIDENT AND CEO by reporting person's trust 3

2020-04-20 G 122,661 d 0 662,869.00 indirect

GIANAKAKOS ANASTASIOS - Director - Officer PRESIDENT AND CEO

2020-04-17 G 200,865 a 277,661 662,869.00 direct

GIANAKAKOS ANASTASIOS - Director - Officer PRESIDENT AND CEO by reporting person's trust 3

2020-04-17 G 200,865 d 122,661 662,869.00 indirect

GIANAKAKOS ANASTASIOS - Director - Officer PRESIDENT AND CEO

2020-04-16 S 1,000 $55.00 d 76,796 662,869.00 direct yes

GIANAKAKOS ANASTASIOS - Director - Officer PRESIDENT AND CEO

2020-04-08 S 1,500 $50.00 d 77,796 663,869.00 direct yes

HARRIS TAYLOR C. - Officer CHIEF FINANCIAL OFFICER

2020-04-06 S 1,305 $46.99 d 7,438 7,438.00 direct

HARRIS TAYLOR C. - Officer CHIEF FINANCIAL OFFICER

2020-04-04 M 3,750 a 8,743 7,438.00 direct

HARRIS TAYLOR C. - Officer CHIEF FINANCIAL OFFICER

2020-04-04 M 3,750 d 7,500 7,438.00 direct

GIANAKAKOS ANASTASIOS - Director - Officer PRESIDENT AND CEO

2020-04-02 S 600 $43.51 d 81,196 665,369.00 direct yes

GIANAKAKOS ANASTASIOS - Director - Officer PRESIDENT AND CEO

2020-04-02 S 300 $45.35 d 79,896 665,369.00 direct yes

GIANAKAKOS ANASTASIOS - Director - Officer PRESIDENT AND CEO

2020-04-02 S 1,000 $44.47 d 80,196 665,369.00 direct yes

GIANAKAKOS ANASTASIOS - Director - Officer PRESIDENT AND CEO

2020-04-02 S 600 $46.23 d 79,296 665,369.00 direct yes

Elevate your investments